Literature DB >> 28497211

Association of toll-like receptor gene polymorphisms and its interaction with HPV infection in determining the susceptibility of cervical cancer in Chinese Han population.

Ye Jin1, Shuang Qiu1, Na Shao1, Jianhua Zheng2.   

Abstract

The aim of the study is to investigate the association of several single-nucleotide polymorphisms (SNPs) within Toll-like receptors (TLRs) gene and additional gene-gene and gene-human papillomavirus (HPV) infection interaction with cervical cancer risk. A total of 1262 participants are selected, including 420 cervical cancer patients and 842 control participants. Generalized multifactor dimensionality reduction (GMDR) was used to screen the best interaction combination among five SNPs within TLR gene and HPV infection. Logistic regression was performed to calculate the ORs (95 %CI) for association of five SNPs within TLR gene and additional gene-HPV infection interaction with cervical cancer risk. Cervical cancer risk was significantly higher in carriers of the T allele of rs3775290 within TLR2 gene, the G allele of rs7873784 within TLR4 gene, and the A allele of rs352140 within TLR9 gene than those with wild genotype; adjusted ORs (95 %CI) were 1.78 (1.20-2.24), 1.65 (1.23-2.12), and 1.70 (1.16-2.31). However, we did not find any significant association of rs4986791 and rs11536889 with cervical cancer risk. GMDR analysis suggested a significant two-locus model (p = 0.0107) involving rs352140 and HPV infection. Subjects with HPV infection and rs352140-GA + AA genotype within TLR9 gene have the highest cervical cancer risk, compared to no HPV infection participants with rs352140-GG genotype, OR (95 %CI) = 3.22 (1.68-4.81). Pairwise LD analysis did not find any significant haplotype combination associated with cervical cancer risk. The minor alleles of TLR2-rs3775290, TLR4-rs7873784, and TLR9-rs352140, and interaction between rs352140 and HPV infection were all associated with increased cervical cancer risk.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28497211     DOI: 10.1007/s00335-017-9691-x

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  23 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 2.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

3.  Screening for cervical cancer.

Authors:  Guglielmo Ronco; Chris J L Meijer; Jack Cuzick; Paolo Giorgi-Rossi; Julian Peto; Nereo Segnan; Joakim Dillner
Journal:  Ann Intern Med       Date:  2012-04-17       Impact factor: 25.391

4.  Gene Polymorphisms of Toll-Like Receptor 9 -1486T/C and 2848G/A in Cervical Cancer Risk.

Authors:  Xiyan Mu; Jitong Zhao; Xin Yuan; Xitong Zhao; Kui Yao; Yingwei Liu; Xia Zhao
Journal:  Int J Gynecol Cancer       Date:  2015-09       Impact factor: 3.437

5.  A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence.

Authors:  Xiang-Yang Lou; Guo-Bo Chen; Lei Yan; Jennie Z Ma; Jun Zhu; Robert C Elston; Ming D Li
Journal:  Am J Hum Genet       Date:  2007-04-25       Impact factor: 11.025

6.  TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections.

Authors:  Fabiana Cannella; Alessandra Pierangeli; Carolina Scagnolari; Giulia Cacciotti; Giulia Tranquilli; Patrizia Stentella; Nadia Recine; Guido Antonelli
Journal:  Immunobiology       Date:  2014-10-23       Impact factor: 3.144

7.  Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more than 10 years.

Authors:  Shu-Fen Liao; Wen-Chung Lee; Hui-Chi Chen; Li-Chung Chuang; Mei-Hung Pan; Chien-Jen Chen
Journal:  Cancer Causes Control       Date:  2012-03-27       Impact factor: 2.506

8.  Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.

Authors:  Sabrina Zidi; Hasibe Verdi; Yaprak Yilmaz-Yalcin; A C Yazici; Ezzedine Gazouani; Amel Mezlini; Fatma-Belgin Atac; Besma Yacoubi-Loueslati
Journal:  Bull Cancer       Date:  2014-10       Impact factor: 1.276

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women.

Authors:  Saumya Pandey; Rama Devi Mittal; Madhu Srivastava; Kirti Srivastava; Shalini Singh; Shruti Srivastava; Balraj Mittal
Journal:  Gynecol Oncol       Date:  2009-06-21       Impact factor: 5.482

View more
  6 in total

1.  The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.

Authors:  Shasha Yang; Lan Liu; Dongyuan Xu; Xiangdan Li
Journal:  Pathol Oncol Res       Date:  2018-09-13       Impact factor: 3.201

2.  Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.

Authors:  Nilesh O Pandey; Alex V Chauhan; Nitin S Raithatha; Purvi K Patel; Ronak Khandelwal; Ajesh N Desai; Yesha Choxi; Rutul S Kapadia; Neeraj D Jain
Journal:  Sci Rep       Date:  2019-07-05       Impact factor: 4.379

3.  A Meta-Analysis for Association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629, and TLR9 rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma.

Authors:  Seyedeh Fatemeh Parsaeian; Fatemeh Asadian; Mojgan Karimi-Zarchi; Sepideh Setayesh; Atiyeh Javaheri; Razieh Sadat Tabatabaie; Seyed Alireza Dastgheib; Hossein Golestanpour; Hossein Neamatzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2021-11-01

4.  Comprehensive assessment of association between TLR4 gene polymorphisms and cancer risk: a systematic meta-analysis.

Authors:  Lu Ding; Qifeng Jiang; Guang Li; Jia Shen; Jiayin Du; Xiaochen Lu; Xingliang Xiong
Journal:  Oncotarget       Date:  2017-10-06

5.  Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer.

Authors:  Alex Chauhan; Nilesh Pandey; Nitin Raithatha; Purvi Patel; Ajesh Desai; Neeraj Jain
Journal:  F1000Res       Date:  2018-05-17

Review 6.  The Associations between Toll-Like Receptor 9 Gene Polymorphisms and Cervical Cancer Susceptibility.

Authors:  Sijuan Tian; Liping Zhang; Ting Yang; Xing Wei; Li Zhang; Yang Yu; Yang Li; Di Cao; Xiaofeng Yang
Journal:  Mediators Inflamm       Date:  2018-07-25       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.